Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Metabolic Syndrome MeSH Descriptor Data 2025


MeSH Heading
Metabolic Syndrome
Tree Number(s)
C18.452.394.968.500.570
C18.452.625
Unique ID
D024821
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D024821
Scope Note
A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
Entry Term(s)
Cardiometabolic Syndrome
Dysmetabolic Syndrome X
Insulin Resistance Syndrome X
Metabolic Cardiovascular Syndrome
Metabolic Syndrome X
Metabolic X Syndrome
Reaven Syndrome X
Syndrome X, Insulin Resistance
Syndrome X, Metabolic
NLM Classification #
WK 880
Previous Indexing
Insulin Resistance (1992-2001)
Syndrome X (1996-2001)
See Also
Cardiometabolic Risk Factors
Diabetes Mellitus, Type 2
Microvascular Angina
Public MeSH Note
2018; see METABOLIC SYNDROME X 2002-2017; for REAVEN SYNDROME X see INSULIN RESISTANCE 1998-2001
History Note
2018 (2002); for REAVEN SYNDROME X use INSULIN RESISTANCE 1998-2001
Date Established
2002/01/01
Date of Entry
2001/07/25
Revision Date
2020/02/28
Metabolic Syndrome Preferred
Cardiometabolic Syndrome Related
page delivered in 0.148s